CDT Equity Inc.
USUSDCDT Equity Inc. (US:CDT) — Biotechnology: Pharmaceutical Preparations. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 1. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- cdtequity.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hauptsitz
- NAPLES, United States
- CEO
- James Bligh
- Mitarbeiter
- 4
- Ausstehende Aktien
- 6.31 Mio. Stand 2026-07-15
- Streubesitz
- 22 431
- Marktkapitalisierung
- 763 020 USD
- Insider
- 32.85%
- Institutionelle Anleger
- 0.07%
- Branche (SIC)
- Pharmaceutical Preparations
- FCF
- −16.0 Mio. USD
- Schulden
- 800 Tsd. USD
- Gewinne und FCF – für die 12 Monate bis 30.06.2026 (aktueller Bericht des Unternehmens).
Beschreibung
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Börsen und Ticker
| Börse | Ticker | Währung | Preis | Typ |
|---|---|---|---|---|
| US USA Stocks | CDT | USD | 0.718 -10.25% | Stammaktie |
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| Jane Street Group, LLC | 0.03% | 6 119 | 2026-06-30 |
| Citadel Advisors Llc | 0.02% | 3 230 | 2026-06-30 |
| Virtu Financial LLC | 0.01% | 2 724 | 2026-06-30 |
| Geode Capital Management… | 0.01% | 1 674 | 2026-06-30 |
| Xtx Topco Ltd | 0.01% | 1 292 | 2026-06-30 |
| Financial Management Pro… | 0.01% | 1 001 | 2026-06-30 |
| Tower Research Capital L… | 0% | 910 | 2026-06-30 |
| Fidelity Concord Street… | 0% | 59 | 2026-07-31 |
| Fidelity Concord Street… | 0% | 8 | 2026-07-31 |
